Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies

Craig LaForce,1 Eric Derom,2 Ulrich Bothner,3 Isabel M Kloer,3 Matthias Trampisch,4 Roland Buhl5 1NC Clinical Research, Raleigh, NC, USA; 2Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium; 3Pharmacovigilance, Boehringer Ingelheim International GmbH, Ingelheim, Germany;...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	LaForce C, Derom E, Bothner U, Kloer IM, Trampisch M, Buhl R
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Dove Medical Press 2018-06-01
Seri Bilgileri:	International Journal of COPD
Konular:	COPD renal impairment comorbidities tiotropium olodaterol safety
Online Erişim:	https://www.dovepress.com/long-term-safety-of-tiotropiumolodaterol-respimatreg-in-patients-with--peer-reviewed-article-COPD
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!